Baker Bros. Advisors »

Skye Bioscience shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Skye Bioscience (SKYE) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Skye Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Skye Bioscience held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Skye Bioscience by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.0M 500k 8.01

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeiGene Sponsored Adr (BGNE)
ACADIA Pharmaceuticals (ACAD)
Madrigal Pharmaceuticals (MDGL)
Revolution Medicines (RVMD)
Rhythm Pharmaceuticals (RYTM)
Insmed Incorporated Com Par $.01 (INSM)
Bicycle Therapeutics Sponsored Ads (BCYC)
Summit Therapeutics (SMMT)
Kymera Therapeutics (KYMR)
Edgewise Therapeutics (EWTX)
Alkermes SHS (ALKS)
Insmed Incorporated Note 0.75% 6/1/2028 (Principal)
Replimune Group (REPL)
Denali Therapeutics (DNLI)

View all positions for Baker Bros. Advisors

Top funds holding Skye Bioscience

5AM Venture Management
Versant Venture Management
Altium Capital Management
Logos Global Management
Sphera Funds Management
BlackRock
Henderson Group
Vanguard Group
CVI Holdings
Driehaus Capital Management
Point72 Asset Management
Baker Bros. Advisors
Perceptive Advisors
Schonfeld Strategic Advisors
Geode Capital Management

View all funds holding Skye Bioscience